{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:52:36Z","timestamp":1792788756285,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shenzhen Second People\u00e2\u20ac\u2122s Hospital Clinical Research Fund of the Shenzhen High-level Hospital Construction Project","award":["No. 20243357001"],"award-info":[{"award-number":["No. 20243357001"]}]},{"name":"Gathering Disciples Mentorship Program of the Medical School of Shenzhen University","award":["202203"],"award-info":[{"award-number":["202203"]}]},{"name":"Research Projects of the Health Commission of the Guangxi Zhuang Autonomous Region","award":["No. Z20190285"],"award-info":[{"award-number":["No. Z20190285"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,25]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Neuronal ceroid lipofuscinoses (NCLs) are rare, fatal, inherited neurodegenerative disorders characterized by myoclonic epilepsy, cognitive decline, brain atrophy, and retinopathy. The pathogenesis and clinical manifestations of NCL are not well understood and frequently result in misdiagnosis and overtreatment. The aim of this case report and review is to improve our understanding of the clinical features and management of NCL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 36-year-old woman initially presented with refractory epilepsy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Initially diagnosed with autoimmune encephalitis, the patient was later diagnosed with normal-pressure hydrocephalus. A definitive diagnosis of adult-onset neuronal ceroid lipofuscinosis (ANCL) was established after 10 years of observation, utilizing biopsy and genetic testing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>High-dose intravenous immunoglobulin and methylprednisolone were administered, along with the insertion of a ventriculoperitoneal shunt.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Despite various treatments, the patient\u2019s condition did not improve.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>ANCL typically presents with the clinical triad of refractory seizures, progressive cognitive decline, and movement disorders. Neuroimaging often reveals progressive brain atrophy on magnetic resonance imaging, while electroencephalograms frequently show epileptiform discharges. The prognosis is generally poor. Improved understanding of ANCL from both clinical and radiological perspectives, coupled with early consideration of differential diagnoses, could minimize unnecessary interventions and optimize patient care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000040248","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T15:04:03Z","timestamp":1730214243000},"page":"e40248","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":31,"title":["Adult-onset neuronal ceroid lipofuscinosis misdiagnosed as autoimmune encephalitis and normal-pressure hydrocephalus: A 10-year case report and case-based review"],"prefix":"10.1097","volume":"103","author":[{"given":"Huasheng","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Neurology, Liuzhou People\u2019s Hospital, Liuzhou, Guangxi Zhuang Autonomous Region, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4663-1815","authenticated-orcid":false,"given":"Yuqi","family":"Liao","sequence":"additional","affiliation":[{"name":"School of Medicine, Shenzhen University, Shenzhen, Guangdong Province, China"},{"name":"Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanni","family":"Yu","sequence":"additional","affiliation":[{"name":"School of Medicine, Shenzhen University, Shenzhen, Guangdong Province, China"},{"name":"Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HuiHui","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Liuzhou People\u2019s Hospital, Liuzhou, Guangxi Zhuang Autonomous Region, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Zhi","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Neurology, Liuzhou People\u2019s Hospital, Liuzhou, Guangxi Zhuang Autonomous Region, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2836-9347","authenticated-orcid":false,"given":"Liming","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen, China"},{"name":"Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, Hunan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.3390\/molecules26206235","article-title":"Patient-derived induced pluripotent stem cell models for phenotypic screening in the neuronal ceroid lipofuscinoses.","volume":"26","author":"Morsy","year":"2021","journal-title":"Molecules"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.3390\/ijms23105729","article-title":"Recent insight into the genetic basis, clinical features, and diagnostic methods for neuronal ceroid lipofuscinosis.","volume":"23","author":"Kamini\u00f3w","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1212\/WNL.0000000000002943","article-title":"Diagnosis and misdiagnosis of adult neuronal ceroid lipofuscinosis (Kufs disease).","volume":"87","author":"Berkovic","year":"2016","journal-title":"Neurology"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ajmg.1320310606","article-title":"Batten disease: past, present, and future.","volume":"31","author":"Rider","year":"1988","journal-title":"Am J Med Genet Suppl"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0387-7604(88)80075-5","article-title":"Neuronal ceroid-lipofuscinoses in childhood.","volume":"10","author":"Santavuori","year":"1988","journal-title":"Brain Dev"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-510X(01)00546-9","article-title":"Autosomal dominant Kufs\u2019 disease: a cause of early onset dementia.","volume":"188","author":"Josephson","year":"2001","journal-title":"J Neurol Sci"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1111\/epi.12632","article-title":"Recurrent generalized seizures, visual loss, and palinopsia as phenotypic features of neuronal ceroid lipofuscinosis due to progranulin gene mutation.","volume":"55","author":"Canafoglia","year":"2014","journal-title":"Epilepsia"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/hmg\/dds558","article-title":"Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis.","volume":"22","author":"Smith","year":"2013","journal-title":"Hum Mol Genet"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ajhg.2011.07.003","article-title":"Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis.","volume":"89","author":"Noskov\u00e1","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12883-015-0357-6","article-title":"Brain imaging in Kufs disease type B: case reports.","volume":"15","author":"Di Fabio","year":"2015","journal-title":"BMC Neurol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/mds.20406","article-title":"Adult-onset neuronal ceroid lipofuscinosis type B in an African-American.","volume":"20","author":"Ivan","year":"2005","journal-title":"Mov Disord"},{"issue":"Pt 1","key":"R12-20250504","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/brain\/111.1.27","article-title":"Kufs\u2019 disease: a critical reappraisal.","volume":"111","author":"Berkovic","year":"1988","journal-title":"Brain"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1684\/epd.2017.0911","article-title":"Long-term follow-up of two siblings with adult-onset neuronal ceroid lipofuscinosis, Kufs type A.","volume":"19","author":"\u00d6zkara","year":"2017","journal-title":"Epileptic Disord"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.nbd.2011.02.009","article-title":"A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers.","volume":"42","author":"Farias","year":"2011","journal-title":"Neurobiol Dis"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00401-015-1512-2","article-title":"Neuronal ceroid lipofuscinosis with DNAJC5\/CSP\u03b1 mutation has PPT1 pathology and exhibit aberrant protein palmitoylation.","volume":"131","author":"Henderson","year":"2016","journal-title":"Acta Neuropathol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/15548627.2022.2065618","article-title":"Abnormal triaging of misfolded proteins by adult neuronal ceroid lipofuscinosis-associated DNAJC5\/CSP\u03b1 mutants causes lipofuscin accumulation.","volume":"19","author":"Lee","year":"2023","journal-title":"Autophagy"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"37330","DOI":"10.1074\/jbc.M112.389098","article-title":"Palmitoylation-induced aggregation of cysteine-string protein mutants that cause neuronal ceroid lipofuscinosis.","volume":"287","author":"Greaves","year":"2012","journal-title":"J Biol Chem"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/cge.13829","article-title":"Autosomal dominant neuronal ceroid lipofuscinosis: clinical features and molecular basis.","volume":"99","author":"Naseri","year":"2021","journal-title":"Clin Genet"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/cge.12020","article-title":"Recurrent mutations in DNAJC5 cause autosomal dominant Kufs disease.","volume":"83","author":"Cadieux-Dion","year":"2013","journal-title":"Clin Genet"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1750-3639.2003.tb00486.x","article-title":"Autosomal dominant adult neuronal ceroid lipofuscinosis: a novel form of NCL with granular osmiophilic deposits without palmitoyl protein thioesterase 1 deficiency.","volume":"13","author":"Nijssen","year":"2003","journal-title":"Brain Pathol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ajhg.2011.04.004","article-title":"Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6.","volume":"88","author":"Arsov","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pediatrneurol.2008.10.012","article-title":"A 30-year follow-up of a neuronal ceroid lipofuscinosis patient with mutations in CLN3 and protracted disease course.","volume":"40","author":"Aberg","year":"2009","journal-title":"Pediatr Neurol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3174\/ajnr.A4978","article-title":"MRI brain volume measurements in infantile neuronal ceroid lipofuscinosis.","volume":"38","author":"Baker","year":"2017","journal-title":"AJNR Am J Neuroradiol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"e93814","DOI":"10.1371\/journal.pone.0093814","article-title":"The \u201cswallow tail\u201d appearance of the healthy nigrosome - a new accurate test of Parkinson\u2019s disease: a case-control and retrospective cross-sectional MRI study at 3T.","volume":"9","author":"Schwarz","year":"2014","journal-title":"PLoS One"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/brain\/awy312","article-title":"Kufs or not Kufs: challenging diagnostics of a rare adult-onset neurodegenerative disease.","volume":"142","author":"Tyynel\u00e4","year":"2019","journal-title":"Brain"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2174\/138920111795542633","article-title":"Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses.","volume":"12","author":"Kohan","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(18)30368-5","article-title":"Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis.","volume":"18","author":"Mole","year":"2019","journal-title":"Lancet Neurol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/21678707.2019.1684258","article-title":"Advances in the treatment of neuronal ceroid lipofuscinosis.","volume":"7","author":"Rosenberg","year":"2019","journal-title":"Expert Opin Orphan Drugs"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13023-018-0798-2","article-title":"Neural stem cells for disease modeling and evaluation of therapeutics for infantile (CLN1\/PPT1) and late infantile (CLN2\/TPP1) neuronal ceroid lipofuscinoses.","volume":"13","author":"Sima","year":"2018","journal-title":"Orphanet J Rare Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:54:58Z","timestamp":1746320098000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":29,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040248","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]}}}